 |
 |

The Vasculocardiac Syndrome of Metastatic Carcinoid
WILLIAM B. BEAN, M.D.;
DAVID FUNK, M.D.
AMA Arch Intern Med. 1959;103(2):189-199.
 |
 |
| Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings. |
|
 |
 |
In the last few years, serotonin has emerged as a fascinating natural humor of the human body. Its myriad, miscellaneous, and mystifying functions are the delight and confusion of pharmacologists, the fascination and mystery of internists and surgeons, and the hope and bewilderment of psychiatrists and psychologists, as well as a phantom and will-o'-the-wisp for hematologists. The first clue about what we now know as serotonin appeared, but hardly emerged, about 90 years ago when Ludwig demonstrated that blood which had been defibrinated contained a vasoconstrictor principle not demonstrable in the same blood before coagulation. While most of the attention on the clotting mechanism traditionally focused on what had been taken out of blood in the process of clotting, here was a paradoxical situation—something had been added. Rapport and Page sought this mysterious vasoconstrictor and identified it in 1948. Thus 80 years elapsed between the discovery of a biological principle,
. . . [Full Text PDF of this Article]
Author Affiliations
Iowa City
From the Department of Medicine and the University Hospitals of the State University of Iowa College of Medicine.
Footnotes
Submitted for publication Feb. 11, 1958.
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
|